Anna Louise French, Director at Jasper Therapeutics, Inc. (JSPR), sold 7,000 shares at $1.48 ($10K) on 2023-04-14, disclosed to the SEC on 2023-04-14.
Open-market sale of $10k JSPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.